CORVIDIA
Corvidia Therapeutics is a clinical stage company focused on the research, development, and commercialization of transformative therapies for cardio-renal diseases. The Company is currently developing potential treatments for chronic kidney disease with atherosclerotic cardiovascular disease and inflammation, and high triglyceride-induced acute pancreatitis.
CORVIDIA
Social Links:
Industry:
Biotechnology Genetics Health Care Medical Therapeutics
Founded:
2014-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.corvidiatx.com
Total Employee:
11+
Status:
Active
Contact:
781-205-4755
Email Addresses:
[email protected]
Total Funding:
86.83 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail WordPress 5.8 Mimecast Dyn DNS SingleHop
Current Advisors List
![]()

![]()
Founder
![]()
![]()
![]()
Investors List
![]()
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Convertible Note - Corvidia
Sofinnova Partners
Sofinnova Partners investment in Series B - Corvidia
![]()
MedImmune
MedImmune investment in Series B - Corvidia
Andera Partners
Andera Partners investment in Series B - Corvidia
![]()
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Corvidia
![]()
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series B - Corvidia
Venrock
Venrock investment in Series B - Corvidia
Fresenius Medical Care
Fresenius Medical Care investment in Series B - Corvidia
Apple Tree Partners
Apple Tree Partners investment in Series B - Corvidia
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series B - Corvidia
Official Site Inspections
http://www.corvidiatx.com
- Host name: 172.67.141.32
- IP address: 172.67.141.32
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
